Reem Berro, Ph.D. - Publications

Affiliations: 
2007 The George Washington University, Washington, DC, United States 
Area:
Genetics

22 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2013 Berro R, Yasmeen A, Abrol R, Trzaskowski B, Abi-Habib S, Grunbeck A, Lascano D, Goddard WA, Klasse PJ, Sakmar TP, Moore JP. Use of G-protein-coupled and -uncoupled CCR5 receptors by CCR5 inhibitor-resistant and -sensitive human immunodeficiency virus type 1 variants Journal of Virology. 87: 6569-6581. PMID 23468486 DOI: 10.1128/JVI.00099-13  0.6
2013 Parker ZF, Iyer SS, Wilen CB, Parrish NF, Chikere KC, Lee FH, Didigu CA, Berro R, Klasse PJ, Lee B, Moore JP, Shaw GM, Hahn BH, Doms RW. Transmitted/founder and chronic HIV-1 envelope proteins are distinguished by differential utilization of CCR5. Journal of Virology. 87: 2401-11. PMID 23269796 DOI: 10.1128/JVI.02964-12  0.6
2012 Berro R, Klasse PJ, Jakobsen MR, Gorry PR, Moore JP, Sanders RW. V3 determinants of HIV-1 escape from the CCR5 inhibitors Maraviroc and Vicriviroc. Virology. 427: 158-65. PMID 22424737 DOI: 10.1016/j.virol.2012.02.006  0.6
2012 Berro R, Klasse PJ, Jakobsen MR, Gorry PR, Moore JP, Sanders RW. Corrigendum to "V3 determinants of HIV-1 escape from the CCR5 inhibitors Maraviroc and Vicriviroc" [Virology 427 (2012) 158-165] Virology. 428: 76. DOI: 10.1016/j.virol.2012.04.001  0.6
2011 Berro R, Klasse PJ, Lascano D, Flegler A, Nagashima KA, Sanders RW, Sakmar TP, Hope TJ, Moore JP. Multiple CCR5 conformations on the cell surface are used differentially by human immunodeficiency viruses resistant or sensitive to CCR5 inhibitors. Journal of Virology. 85: 8227-40. PMID 21680525 DOI: 10.1128/JVI.00767-11  0.6
2009 Berro R, Sanders RW, Lu M, Klasse PJ, Moore JP. Two HIV-1 variants resistant to small molecule CCR5 inhibitors differ in how they use CCR5 for entry Plos Pathogens. 5. PMID 19680536 DOI: 10.1371/journal.ppat.1000548  0.6
2008 Martinez NW, Xue X, Berro RG, Kreitzer G, Resh MD. Kinesin KIF4 regulates intracellular trafficking and stability of the human immunodeficiency virus type 1 Gag polyprotein. Journal of Virology. 82: 9937-50. PMID 18684836 DOI: 10.1128/JVI.00819-08  0.6
2008 Agbottah E, Yeh WI, Berro R, Klase Z, Pedati C, Kehn-Hall K, Wu W, Kashanchi F. Two specific drugs, BMS-345541 and purvalanol A induce apoptosis of HTLV-1 infected cells through inhibition of the NF-kappaB and cell cycle pathways. Aids Research and Therapy. 5: 12. PMID 18544167 DOI: 10.1186/1742-6405-5-12  0.64
2008 Van Duyne R, Easley R, Wu W, Berro R, Pedati C, Klase Z, Kehn-Hall K, Flynn EK, Symer DE, Kashanchi F. Lysine methylation of HIV-1 Tat regulates transcriptional activity of the viral LTR. Retrovirology. 5: 40. PMID 18498648 DOI: 10.1186/1742-4690-5-40  0.64
2008 Berro R, Pedati C, Kehn-Hall K, Wu W, Klase Z, Even Y, Genevière AM, Ammosova T, Nekhai S, Kashanchi F. CDK13, a new potential human immunodeficiency virus type 1 inhibitory factor regulating viral mRNA splicing. Journal of Virology. 82: 7155-66. PMID 18480452 DOI: 10.1128/JVI.02543-07  0.64
2007 Klase Z, Kale P, Winograd R, Gupta MV, Heydarian M, Berro R, McCaffrey T, Kashanchi F. HIV-1 TAR element is processed by Dicer to yield a viral micro-RNA involved in chromatin remodeling of the viral LTR. Bmc Molecular Biology. 8: 63. PMID 17663774 DOI: 10.1186/1471-2199-8-63  0.64
2007 Kehn K, Berro R, Alhaj A, Bottazzi ME, Yeh WI, Klase Z, Van Duyne R, Fu S, Kashanchi F. Functional consequences of cyclin D1/BRCA1 interaction in breast cancer cells. Oncogene. 26: 5060-9. PMID 17334399 DOI: 10.1038/sj.onc.1210319  0.64
2007 Berro R, de la Fuente C, Klase Z, Kehn K, Parvin L, Pumfery A, Agbottah E, Vertes A, Nekhai S, Kashanchi F. Identifying the membrane proteome of HIV-1 latently infected cells. The Journal of Biological Chemistry. 282: 8207-18. PMID 17237230 DOI: 10.1074/jbc.M606324200  0.6
2006 Ammosova T, Berro R, Jerebtsova M, Jackson A, Charles S, Klase Z, Southerland W, Gordeuk VR, Kashanchi F, Nekhai S. Phosphorylation of HIV-1 Tat by CDK2 in HIV-1 transcription. Retrovirology. 3: 78. PMID 17083724 DOI: 10.1186/1742-4690-3-78  0.6
2006 Pumfery A, de la Fuente C, Berro R, Nekhai S, Kashanchi F, Chao SH. Potential use of pharmacological cyclin-dependent kinase inhibitors as anti-HIV therapeutics. Current Pharmaceutical Design. 12: 1949-61. PMID 16787240  0.64
2006 Berro R, Kehn K, de la Fuente C, Pumfery A, Adair R, Wade J, Colberg-Poley AM, Hiscott J, Kashanchi F. Acetylated Tat regulates human immunodeficiency virus type 1 splicing through its interaction with the splicing regulator p32. Journal of Virology. 80: 3189-204. PMID 16537587 DOI: 10.1128/JVI.80.7.3189-3204.2006  0.6
2006 Iordanskiy S, Berro R, Altieri M, Kashanchi F, Bukrinsky M. Intracytoplasmic maturation of the human immunodeficiency virus type 1 reverse transcription complexes determines their capacity to integrate into chromatin. Retrovirology. 3: 4. PMID 16409631 DOI: 10.1186/1742-4690-3-4  0.6
2005 Haffar O, Dubrovsky L, Lowe R, Berro R, Kashanchi F, Godden J, Vanpouille C, Bajorath J, Bukrinsky M. Oxadiazols: a new class of rationally designed anti-human immunodeficiency virus compounds targeting the nuclear localization signal of the viral matrix protein. Journal of Virology. 79: 13028-36. PMID 16189005 DOI: 10.1128/JVI.79.20.13028-13036.2005  0.6
2005 Ammosova T, Berro R, Kashanchi F, Nekhai S. RNA interference directed to CDK2 inhibits HIV-1 transcription. Virology. 341: 171-8. PMID 16085226 DOI: 10.1016/j.virol.2005.06.041  0.64
2005 Kehn K, Fuente Cde L, Strouss K, Berro R, Jiang H, Brady J, Mahieux R, Pumfery A, Bottazzi ME, Kashanchi F. The HTLV-I Tax oncoprotein targets the retinoblastoma protein for proteasomal degradation. Oncogene. 24: 525-40. PMID 15580311 DOI: 10.1038/sj.onc.1208105  0.64
2004 Seelamgari A, Maddukuri A, Berro R, de la Fuente C, Kehn K, Deng L, Dadgar S, Bottazzi ME, Ghedin E, Pumfery A, Kashanchi F. Role of viral regulatory and accessory proteins in HIV-1 replication. Frontiers in Bioscience : a Journal and Virtual Library. 9: 2388-413. PMID 15353294  0.6
2004 Kehn K, Berro R, de la Fuente C, Strouss K, Ghedin E, Dadgar S, Bottazzi ME, Pumfery A, Kashanchi F. Mechanisms of HTLV-1 transformation. Frontiers in Bioscience : a Journal and Virtual Library. 9: 2347-72. PMID 15353292  0.6
Show low-probability matches.